Mutant isocitrate dehydrogenase 1 inhibitor ivosidenib in combination with azacitidine for newly diagnosed acute myeloid leukemia

Courtney D. DiNardo, Anthony S. Stein, Eytan M. Stein, Amir T. Fathi, Olga Frankfurt, Andre C. Schuh, Hartmut Döhner, Giovanni Martinelli, Prapti A. Patel, Emmanuel Raffoux, Peter Tan, Amer M. Zeidan, Stéphane de Botton, Hagop M. Kantarjian, Richard M. Stone, Mark G. Frattini, Frederik Lersch, Jing Gong, Diego A. Gianolio, Vickie ZhangAleksandra Franovic, Bin Fan, Meredith Goldwasser, Scott Daigle, Sung Choe, Bin Wu, Thomas Winkler, Paresh Vyas

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Mutant isocitrate dehydrogenase 1 inhibitor ivosidenib in combination with azacitidine for newly diagnosed acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences